| Tommie Mack Richardson, MD | |
|
400 Technology Ct Se Ste J, Smyrna, GA 30082-5237 | |
| (770) 866-5700 | |
| (770) 436-7143 |
| Full Name | Tommie Mack Richardson |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 52 Years |
| Location | 400 Technology Ct Se Ste J, Smyrna, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013006584 | NPI | - | NPPES |
| 000471479F | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | 031313 (Georgia) | Secondary |
| 207QA0401X | Family Medicine - Addiction Medicine | 31313 (Georgia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Personal Recovery Network Llc | 5092611384 | 251 |
News Archive
People with cataract-related vision loss who have had cataract surgery to improve their sight are living longer than those with visual impairment who chose not to have the procedure, according to an Australian cohort study published this month in Ophthalmology, the journal of the American Academy of Ophthalmology. After comparing the two groups, the researchers found a 40 percent lower long-term mortality risk in those who had the surgery.
In Medicare news, doctors may not be leaving the Medicare program in droves as some think. Sen. Tammy Baldwin is pushing back against Medicare cuts to rural hospital reimbursement, and some hospitals are making follow-up care changes to lower readmission rates.
The parents of a young British girl brought up on a strict vegan diet could face court after the child was admitted to hospital with a degenerative bone condition.
VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 agonists for the treatment of cancer, respiratory and autoimmune diseases, today announced the presentation of results from a Phase 1 clinical trial of VTX-2337, a selective TLR8 agonist in patients with advanced solid tumors. Data were presented at the American Society of Clinical Oncology Annual Meeting in Chicago, IL.
› Verified 2 days ago
| Entity Name | Personal Recovery Network Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881990869 PECOS PAC ID: 5092611384 Enrollment ID: O20120110000096 |
News Archive
People with cataract-related vision loss who have had cataract surgery to improve their sight are living longer than those with visual impairment who chose not to have the procedure, according to an Australian cohort study published this month in Ophthalmology, the journal of the American Academy of Ophthalmology. After comparing the two groups, the researchers found a 40 percent lower long-term mortality risk in those who had the surgery.
In Medicare news, doctors may not be leaving the Medicare program in droves as some think. Sen. Tammy Baldwin is pushing back against Medicare cuts to rural hospital reimbursement, and some hospitals are making follow-up care changes to lower readmission rates.
The parents of a young British girl brought up on a strict vegan diet could face court after the child was admitted to hospital with a degenerative bone condition.
VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 agonists for the treatment of cancer, respiratory and autoimmune diseases, today announced the presentation of results from a Phase 1 clinical trial of VTX-2337, a selective TLR8 agonist in patients with advanced solid tumors. Data were presented at the American Society of Clinical Oncology Annual Meeting in Chicago, IL.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tommie Mack Richardson, MD 4015 S Cobb Dr, #115, Smyrna, GA 30080 Ph: (770) 431-2354 | Tommie Mack Richardson, MD 400 Technology Ct Se Ste J, Smyrna, GA 30082-5237 Ph: (770) 866-5700 |
News Archive
People with cataract-related vision loss who have had cataract surgery to improve their sight are living longer than those with visual impairment who chose not to have the procedure, according to an Australian cohort study published this month in Ophthalmology, the journal of the American Academy of Ophthalmology. After comparing the two groups, the researchers found a 40 percent lower long-term mortality risk in those who had the surgery.
In Medicare news, doctors may not be leaving the Medicare program in droves as some think. Sen. Tammy Baldwin is pushing back against Medicare cuts to rural hospital reimbursement, and some hospitals are making follow-up care changes to lower readmission rates.
The parents of a young British girl brought up on a strict vegan diet could face court after the child was admitted to hospital with a degenerative bone condition.
VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 agonists for the treatment of cancer, respiratory and autoimmune diseases, today announced the presentation of results from a Phase 1 clinical trial of VTX-2337, a selective TLR8 agonist in patients with advanced solid tumors. Data were presented at the American Society of Clinical Oncology Annual Meeting in Chicago, IL.
› Verified 2 days ago